Role of PET/CT in the functional imaging of endocrine pancreatic tumorsRUFINI, Vittoria; BAUM, Richard P; GIORDANO, Alessandro et al.Abdominal imaging. 2012, Vol 37, Num 6, pp 1004-1020, issn 0942-8925, 17 p.Article

Loss of Nuclear p27 Expression and Its Prognostic Role in Relation to Cyclin E and p53 Mutation in Gastroenteropancreatic Neuroendocrine TumorsGRABOWSKI, Patricia; SCHRADER, Jörg; STURM, Isrid et al.Clinical cancer research (Print). 2008, Vol 14, Num 22, pp 7378-7384, issn 1078-0432, 7 p.Article

Targeting Aurora Kinases with Danusertib (PHA-739358) Inhibits Growth of Liver Metastases from Gastroenteropancreatic Neuroendocrine Tumors in an Orthotopic Xenograft ModelFRAEDRICH, Katharina; SCHRADER, Jörg; LOSE, Ansgar W et al.Clinical cancer research (Print). 2012, Vol 18, Num 17, pp 4621-4632, issn 1078-0432, 12 p.Article

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine TumorsRAYMOND, Eric; DAHAN, Laetitia; CHEN, Jen-Shi et al.The New England journal of medicine. 2011, Vol 364, Num 6, pp 501-513, issn 0028-4793, 13 p.Article

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 studyPAVEL, Marianne E; HAINSWORTH, John D; ÖBERG, Kjell et al.Lancet (British edition). 2011, Vol 378, Num 9808, pp 2005-2012, issn 0140-6736, 8 p.Article

Rap1/B-raf signaling is activated in neuroendocrine tumors of the digestive tract and raf kinase inhibition constitutes a putative therapeutic targetKARHOFF, Dorothee; SAUER, Susanne; SCHRADER, Jörg et al.Neuroendocrinology (Basel). 2007, Vol 85, Num 1, pp 45-53, issn 0028-3835, 9 p.Article

Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor diseaseGRABOWSKI, Patricia; GRISS, Sonja; ARNOLD, Christian N et al.Neuroendocrinology (Basel). 2005, Vol 81, Num 1, pp 1-9, issn 0028-3835, 9 p.Article